Aptamer Enables Consistent Maytansine Delivery through Maintaining Receptor Homeostasis for HER2 Targeted Cancer Therapy
Yan Tan(Army Medical University), Weihong Tan(Petronas (Malaysia)), Zilong Zhao(The University of Texas MD Anderson Cancer Center), Yuanye Su(Hunan University), Dan Wang(University of Bonn), Lili Ai(Hunan University), Ting Fu(Chongqing University of Technology), Xue‐Qiang Wang(Hunan University), Yixin Qu(Hunan University), Tanggang Deng(First Affiliated Hospital of Guangdong Pharmaceutical University), Yingying Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongbo Peng(Chongqing Medical and Pharmaceutical College)
Cited by 11
Related Papers
Conjugation of Biomolecules with Luminophore-Doped Silica Nanoparticles for Photostable Biomarkers
|Analytical Chemistry|2001|748
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
|Nanomedicine|2012|609
Preparation and antibacterial activity of Fe<sub>3</sub>O<sub>4</sub>@Ag nanoparticles
|Nanotechnology|2007|600
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO<sub>2</sub> Nanosheet–Aptamer Nanoprobe
|Journal of the American Chemical Society|2014|585